Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,288 | -12,895 | -7,442 | -3,399 | -12,057 |
| Depreciation Amortization | 733 | 565 | 372 | 177 | 718 |
| Accounts receivable | 228 | -2,402 | -2,030 | -234 | -560 |
| Accounts payable and accrued liabilities | 139 | -81 | -983 | -1,409 | -274 |
| Other Working Capital | 28 | -1,708 | -1,807 | -1,319 | -431 |
| Other Operating Activity | 3,425 | 4,908 | 4,335 | 2,323 | 6,924 |
| Operating Cash Flow | $-15,735 | $-11,613 | $-7,555 | $-3,861 | $-5,680 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,396 | -2,014 | -1,573 | -262 | -120 |
| Net Acquisitions | -225 | -225 | -225 | N/A | 0 |
| Other Investing Activity | 13 | 13 | 4 | 0 | 0 |
| Investing Cash Flow | $-2,608 | $-2,226 | $-1,794 | $-262 | $-120 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,265 |
| Debt Repayment | -25 | -25 | -25 | -25 | -75 |
| Common Stock Issued | 27,930 | 27,930 | 27,600 | N/A | 22,290 |
| Other Financing Activity | -3,738 | -3,738 | -2,234 | 0 | 57 |
| Financing Cash Flow | $24,167 | $24,167 | $25,341 | $-25 | $23,537 |
| Beginning Cash Position | 18,206 | 18,206 | 18,206 | 18,206 | 469 |
| End Cash Position | 24,030 | 28,534 | 34,198 | 14,058 | 18,206 |
| Net Cash Flow | $5,824 | $10,328 | $15,992 | $-4,148 | $17,736 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,735 | -11,613 | -7,555 | -3,861 | -5,680 |
| Capital Expenditure | -2,396 | -2,014 | -1,573 | -262 | -120 |
| Free Cash Flow | -18,131 | -13,627 | -9,128 | -4,123 | -5,800 |